ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 71 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $150,289 | -75.4% | 68,940 | -27.0% | 0.01% | -75.0% |
| Q3 2022 | $612,000 | +55.7% | 94,493 | +8.2% | 0.02% | +81.8% |
| Q2 2022 | $393,000 | -11.7% | 87,365 | +77.3% | 0.01% | +22.2% |
| Q1 2022 | $445,000 | -39.0% | 49,289 | -7.3% | 0.01% | -35.7% |
| Q4 2021 | $729,000 | -34.6% | 53,153 | +6.5% | 0.01% | -33.3% |
| Q3 2021 | $1,115,000 | +56.2% | 49,924 | -6.4% | 0.02% | +75.0% |
| Q2 2021 | $714,000 | +180.0% | 53,364 | -45.8% | 0.01% | +50.0% |
| Q3 2020 | $255,000 | -19.6% | 98,486 | +8.4% | 0.01% | -27.3% |
| Q2 2020 | $317,000 | +268.6% | 90,825 | +573.9% | 0.01% | +120.0% |
| Q1 2018 | $86,000 | -15.7% | 13,478 | +20.0% | 0.01% | -28.6% |
| Q4 2017 | $102,000 | +9.7% | 11,234 | +19.0% | 0.01% | -12.5% |
| Q3 2017 | $93,000 | +34.8% | 9,442 | +6.8% | 0.01% | +33.3% |
| Q2 2017 | $69,000 | – | 8,838 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
| Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
| Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
| Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
| XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
| Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
| Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
| ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
| Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |